10.1161/CIRCULATIONAHA.113.005119
10.1016/j.amjcard.2013.05.063
10.1161/01.CIR.0000140263.20897.42
10.1161/STROKEAHA.113.002329
10.1161/CIRCULATIONAHA.112.129759
10.1016/j.ijcard.2012.12.093
10.1016/S0002-9149(98)00583-9
10.1016/j.ijcard.2013.01.184
10.1161/CIRCULATIONAHA.113.005451
10.1161/CIRCEP.112.970749
10.1161/01.CIR.0000072767.89944.6E
10.1161/STROKEAHA.113.003433
10.1016/S0140-6736(14)61774-8
10.1016/S0002-9343(02)01236-6
10.1016/S0140-6736(14)61373-8
10.1016/S0002-9343(99)80348-9
10.1111/j.1747-4949.2011.00706.x
10.1161/STROKEAHA.113.001884
Ott, 1997, Atrial fibrillation and dementia in a population-based study, The Rotterdam Study. Stroke, 28, 316, 10.1161/01.STR.28.2.316
10.1136/heartjnl-2012-303182
Thrall G Lane D Carroll D Lip GY . Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006;119:448.e1–19.
10.1016/j.ahj.2014.02.003
10.1161/CIRCOUTCOMES.110.958165
10.7326/0003-4819-146-12-200706190-00007
10.1016/S0140-6736(13)62343-0
10.1016/j.ahj.2013.05.015
10.1161/CIRCULATIONAHA.112.000491
10.1161/STROKEAHA.115.009487
10.1001/jamainternmed.2013.11912
Emdin, 2016, Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies, BMJ, 532, h7013, 10.1136/bmj.h7013
10.1016/j.ijcard.2014.09.092
10.1161/CIRCULATIONAHA.105.553438
10.1016/j.amjcard.2013.10.035
10.1016/j.ijcard.2011.04.022
10.1371/journal.pone.0065795
10.1111/j.1540-8159.2009.02335.x
Henry, 2013, Are there gender differences in outcomes after the Cox-Maze procedure for atrial fibrillation?, Innovations (Phila), 8, 190, 10.1097/IMI.0b013e3182a2306c
10.1016/j.genm.2010.06.001
10.1016/j.jacc.2012.03.046
10.1161/CIRCULATIONAHA.114.009892
10.1016/j.jacc.2013.12.015
10.1161/STROKEAHA.110.587980
10.1161/STROKEAHA.114.006072
10.1161/CIRCGENETICS.110.958058
10.1016/j.jacc.2009.11.041
10.1016/j.hrthm.2013.02.018
10.1016/j.hrthm.2012.11.012
10.1016/j.jacc.2012.01.070
10.1016/j.cardiores.2005.04.016
10.1016/j.biopha.2009.09.017
10.1016/j.hrthm.2009.01.010
Venteclef, 2013, Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines, Eur Heart J, 36, 795, 10.1093/eurheartj/eht099
10.1161/01.CIR.0000034511.06350.DF
10.1161/CIRCEP.109.910125
10.1111/j.1540-8167.1994.tb01157.x
10.1161/01.CIR.0000016826.62813.F5
10.1016/j.jacc.2012.11.046
10.1161/01.CIR.0000109495.02213.52
10.1111/j.1540-8167.2007.00906.x
10.1016/j.ehj.2004.04.007
10.1161/CIRCULATIONAHA.105.575332
10.1152/physrev.00031.2009
10.1161/CIRCULATIONAHA.113.006641
10.1161/CIRCULATIONAHA.111.067306
10.1016/S0735-1097(01)01443-7
10.1016/S0735-1097(99)00382-4
10.1016/j.hrthm.2004.06.010
10.1016/j.jacc.2008.01.055
10.1016/S0167-5273(98)00228-9
10.1111/j.1540-8159.1997.tb06115.x
10.1161/CIRCRESAHA.114.303772
10.1056/NEJM199809033391003
10.1111/j.1540-8167.2007.00909.x
10.1161/CIRCULATIONAHA.106.633735
10.1161/01.CIR.0000147781.02738.13
10.1111/j.1540-8167.2006.00546.x
10.1016/0002-8703(59)90274-1
Cox, 1991, The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation, J Thorac Cardiovasc Surg, 101, 406, 10.1016/S0022-5223(19)36723-6
10.1016/j.jacc.2012.05.022
10.1161/CIRCULATIONAHA.113.005421
10.1016/j.ehj.2004.04.015
10.1161/CIRCULATIONAHA.104.518837
10.1016/j.ijcard.2015.05.011
10.1136/bmj.39280.660567.55
10.1161/STROKEAHA.112.654954
Hobbs FD Fitzmaurice DA Mant J Murray E Jowett S Bryan S Raftery J Davies M Lip G . A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005;9:iii–iv, ix–x, 1–74.
10.1161/CIRCULATIONAHA.112.126656
Barrett PM Komatireddy R Haaser S Topol S Sheard J Encinas J Fought AJ Topol EJ . Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med 2014;127:95.e11–97.
10.1097/HCO.0000000000000018
10.1161/CIRCEP.109.877852
10.1161/CIRCULATIONAHA.113.007825
10.1016/j.jacc.2010.08.624
10.1016/j.hrthm.2011.04.022
10.1161/CIRCEP.109.849638
10.1016/S1474-4422(15)70027-X
10.1212/WNL.0000000000002282
10.1016/S1474-4422(13)70310-7
10.1136/bmj.39227.551713.AE
10.1016/j.jacc.2003.08.027
10.1161/CIRCULATIONAHA.114.014343
10.1016/S0735-1097(00)00982-7
10.7326/0003-4819-140-4-200402170-00008
10.1161/CIRCULATIONAHA.106.644484
10.1016/S0002-9149(00)00792-X
10.1016/j.jacc.2014.04.019
10.1016/j.ijcard.2012.06.118
10.1016/S0140-6736(12)61463-9
10.1016/j.jacc.2014.01.023
10.1161/CIRCRESAHA.114.303211
10.1016/j.amjcard.2010.07.038
10.1136/heartjnl-2013-304036
10.1016/j.jacc.2010.09.049
10.1016/j.jacc.2013.07.067
Bonizzi, 2014, Systematic comparison of non-invasive measures for the assessment of atrial fibrillation complexity: a step forward towards standardization of atrial fibrillation electrogram analysis, Europace, 17, 318, 10.1093/europace/euu202
Fabritz, 2016, Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment, Nat Rev Cardiol, 13, 230, 10.1038/nrcardio.2015.194
10.1016/S0735-1097(00)00886-X
10.1111/j.1540-8159.2005.00171.x
10.1016/S0300-8932(10)70266-9
10.1136/heartjnl-2011-300550
10.1016/S0195-668X(03)00261-6
Pepine, 2013, Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials, Clin Med Insights Cardiol, 7, 1, 10.4137/CMC.S10628
10.1016/j.jacc.2003.08.037
10.1016/S0735-1097(03)00338-3
10.1016/j.jacc.2013.01.069
10.1161/CIRCULATIONAHA.111.069450
10.1161/CIRCEP.110.958033
10.1016/j.ahj.2013.04.015
10.1016/S0895-4356(98)00081-X
10.1007/s11136-011-9903-x
10.1016/S0828-282X(06)70922-9
10.1161/CIRCOUTCOMES.114.001303
10.1016/j.amjmed.2014.11.026
Szymanski, 2014, Occurrence of poor sleep quality in atrial fibrillation patients according to the EHRA score, Acta Cardiol, 69, 291, 10.1080/AC.69.3.3027832
10.1007/s00392-011-0320-5
10.1016/j.jacc.2014.09.028
10.1016/j.ahj.2013.10.012
10.1016/j.jacc.2015.06.1314
10.1183/09031936.03.00051502
10.1016/j.jacc.2006.08.060
10.1161/CIRCEP.110.957100
10.1016/j.hrthm.2011.03.038
10.1016/j.jacc.2014.03.048
10.1016/j.amjcard.2009.01.374
10.2174/1573403X11309020005
10.1016/j.jval.2011.09.009
10.1016/j.jacc.2006.01.060
10.1016/j.ijcard.2015.10.220
10.1161/CIRCEP.114.001938
10.1016/j.hlc.2014.09.012
10.1016/ijcard.2013.12.180
10.1016/j.jcmg.2009.05.013
10.1093/ejechocard/jep218
Senechal, 2008, A simple Doppler echocardiography method to evaluate pulmonary capillary wedge pressure in patients with atrial fibrillation, Echocardiography, 25, 57, 10.1111/j.1540-8175.2007.00555.x
10.1016/S0894-7317(99)70145-8
10.1016/j.jacc.2015.03.043
10.1016/j.jacc.2010.01.043
10.1016/j.jacc.2004.11.070
10.1097/MJT.0b013e31804beb59
10.1016/j.ahj.2005.06.036
10.1161/CIRCEP.111.965178
10.1016/j.jacc.2011.11.063
10.1016/S0735-1097(00)00611-2
10.1016/j.jacc.2004.10.068
10.1097/HJH.0b013e32834f03bf
10.1161/01.CIR.0000022665.18619.83
10.1016/j.ehj.2003.08.014
10.1016/j.ahj.2006.01.007
10.1016/j.amjcard.2007.01.030
10.1016/0002-9149(94)90363-8
10.1016/j.jacc.2014.02.537
10.1016/j.amjcard.2014.09.007
10.1016/j.athoracsur.2007.04.036
10.1016/j.athoracsur.2006.04.004
10.1016/j.amjcard.2014.10.027
10.1016/j.ijcard.2013.07.017
10.1016/j.jacc.2011.06.032
10.1111/j.1540-8175.2009.00904.x
10.1016/0003-4975(95)00887-X
Goldstone, 2015, Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis, Ann Cardiothorac Surg, 4, 220
10.1016/j.jacc.2012.06.030
10.1016/j.jdiacomp.2014.09.002
10.1007/s00424-009-0771-y
10.1016/j.amjcard.2014.07.045
10.1161/STROKEAHA.115.009371
10.1186/s12933-014-0123-x
10.1161/CIRCEP.113.001244
10.1016/j.ahj.2007.10.004
Overvad, 2013, Body mass index and adverse events in patients with incident atrial fibrillation, Am J Med, 126, 640, 10.1016/j.amjmed.2012.11.024
10.1016/S0002-9149(99)00066-1
10.1016/j.jacc.2010.10.042
10.1016/j.jacc.2015.03.002
10.1016/j.jacc.2015.06.488
10.1161/CIRCULATIONAHA.107.716712
10.1111/j.1540-8167.2008.01118.x
10.1016/j.jacc.2007.03.040
10.1016/j.amjcard.2012.10.013
Vizzardi E Sciatti E Bonadei I D'Aloia A Curnis A Metra M . Obstructive sleep apnoea-hypopnoea and arrhythmias: new updates. J Cardiovasc Med (Hagerstown) 2014, doi 10.2459/JCM.0000000000000043.
10.2174/157340312803760811
10.1016/j.amjcard.2012.07.001
10.1161/CIRCEP.109.858381
10.1016/j.jacc.2013.03.052
10.1016/j.hrthm.2012.11.015
10.1111/j.1540-8167.2011.02148.x
10.1016/j.amjcard.2011.02.343
10.1016/j.cjca.2013.04.005
10.1016/j.amjcard.2012.12.045
10.1377/hlthaff.2014.0428
Lundstrom, 2014, The effectiveness of structured personal care of type 2 diabetes on recurrent outcomes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP), Diabetologia, 57, 1119
Nieuwlaat, 2007, Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation, The Euro Heart Survey on Atrial Fibrillation. Am Heart J, 153, 1006
10.1016/j.healthpol.2011.10.006
10.1016/S0140-6736(14)61992-9
Tran, 2013, A multidisciplinary atrial fibrillation clinic, Curr Cardiol Rev, 9, 55
10.1016/j.ajem.2012.04.022
10.1161/CIR.0000000000000139
10.1016/j.ijnurstu.2009.12.017
10.1016/j.ahj.2014.10.005
10.1161/01.CIR.0000103131.70301.4F
10.1161/CIRCULATIONAHA.109.873265
10.1007/s00399-014-0327-5
Haemers, 2012, The use of cardiac magnetic resonance imaging in the diagnostic workup and treatment of atrial fibrillation, Cardiol Res Pract, 2012, 658937, 10.1155/2012/658937
10.1016/j.jacc.2012.07.065
Lip GY Al-Khatib SM Cosio FG Banerjee A Savelieva I Ruskin J Blendea D Nattel S De Bono J Conroy JM Hess PL Guasch E Halperin JL Kirchhof P MD GC Camm AJ . Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? J Am Heart Assoc 2014;3:e001179.
Hart, 2007, Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation, Ann Intern Med, 147, 590, 10.7326/0003-4819-147-8-200710160-00018
10.1016/j.hrthm.2015.04.039
10.1016/j.ahj.2013.12.014
10.1161/CIRCOUTCOMES.110.937680
10.1161/CIRCOUTCOMES.113.000192
10.1016/j.amjmed.2012.01.033
10.1001/archinte.159.7.677
10.1016/S0140-6736(07)61233-1
10.1016/S1474-4422(12)70017-0
10.1001/archinte.163.8.936
10.1016/j.jacc.2014.11.046
10.1016/j.jacc.2015.01.044
10.1161/STROKEAHA.115.012609
10.1016/j.jacc.2014.10.052
10.1111/j.1538-7836.2012.04853.x
10.1161/CIRCULATIONAHA.111.038729
10.1016/j.jacc.2012.11.082
10.1016/j.ahj.2005.04.017
10.1016/j.jacc.2011.03.031
10.1016/S0140-6736(16)00741-8
10.1007/s00277-011-1267-3
10.1111/j.1538-7836.2011.04378.x
10.1111/j.1538-7836.2010.04085.x
10.1016/j.jacc.2013.08.1623
10.1161/CIRCULATIONAHA.114.011204
10.1161/CIRCULATIONAHA.114.012061
10.1016/j.amjmed.2014.05.023
10.1016/j.jacc.2014.02.549
10.1161/STROKEAHA.112.664144
10.1016/S0140-6736(14)61943-7
10.1182/blood-2014-03-563577
10.1016/S0140-6736(10)61194-4
10.1161/STROKEAHA.113.000883
Friberg, 2014, Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study, Eur Heart J, 36, 297, 10.1093/eurheartj/ehu139
10.1016/j.amjcard.2015.09.046
10.1016/j.jacc.2010.12.013
10.1161/CIRCULATIONAHA.113.004777
10.1016/j.jacc.2014.09.051
10.1161/CIRCULATIONAHA.114.014113
10.1161/CIRCULATIONAHA.113.003628
Stroke Prevention in Atrial Fibrillation Investigators, 1991, Stroke Prevention in Atrial Fibrillation Study, Final results. Circulation, 84, 527
10.1016/S0140-6736(06)68845-4
10.1161/CIRCULATIONAHA.107.750000
10.1161/STROKEAHA.108.526988
10.1016/j.jacc.2004.05.084
10.7326/0003-4819-52-4-741
Wilson, 1954, The natural history of mitral stenosis, Can Med Assoc J, 71, 323
10.1056/NEJM199402173300717
10.7326/0003-4819-128-11-199806010-00001
10.1161/CIRCOUTCOMES.108.796185
10.1016/j.thromres.2008.09.016
10.1161/CIRCULATIONAHA.112.115386
10.1016/j.jcin.2013.11.010
10.1016/j.jacc.2014.04.029
10.1016/S0140-6736(09)61343-X
10.1161/CIRCULATIONAHA.112.114389
10.1016/j.jacc.2015.04.025
10.1016/j.jacc.2013.03.035
10.1161/CIRCEP.114.001413
10.1016/j.jacc.2014.03.057
10.1016/j.ahj.2004.09.054
10.1016/j.cjca.2013.06.015
10.1016/j.hrthm.2015.03.028
Whitlock, 2014, Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III, Ann Cardiothorac Surg, 3, 45
10.1161/CIRCULATIONAHA.111.074047
10.1016/S1474-4422(07)70274-0
10.1016/S0140-6736(14)60584-5
10.1586/14737175.2014.945435
10.1161/01.STR.0000254600.92975.1f
10.1016/S1474-4422(10)70274-X
10.1016/S1474-4422(12)70042-X
10.1016/S1474-4422(12)70092-3
10.1161/STROKEAHA.112.673558
Paciaroni, 2014, Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?, Thromb Haemost, 111, 14, 10.1160/TH13-08-0667
10.1161/CIRCULATIONAHA.115.015735
Weber R Brenck J Diener HC . Antiplatelet therapy in cerebrovascular disorders. Handb Exp Pharmacol 2012:519–546.
10.1016/j.ahj.2006.06.024
10.1016/j.cjca.2011.10.002
10.1161/CIRCULATIONAHA.110.004747
10.1016/j.jacc.2013.11.013
10.1001/jamacardio.2016.0199
10.1016/j.amjopharm.2009.06.002
10.1016/j.amjmed.2014.05.035
Palareti, 2009, Bleeding with anticoagulation therapy – who is at risk, and how best to identify such patients, Thromb Haemost, 102, 268, 10.1160/TH08-11-0730
10.1016/j.jacc.2014.05.065
Niessner A Tamargo J Morais J Koller L Wassmann S Husted SE Torp-Pedersen C Kjeldsen K Lewis BS Drexel H Kaski JC Atar D Storey RF Lip GY Verheugt FW Agewall S . Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. Eur Heart J;doi:10.1093/eurheartj/ehv676. Published online ahead of print 24 December 2015.
10.1016/S0140-6736(14)61685-8
10.1161/ATVBAHA.114.303402
Felmeden, 2005, Antithrombotic therapy in hypertension: a Cochrane Systematic review, J Hum Hypertens, 19, 185, 10.1038/sj.jhh.1001807
10.1161/CIRCULATIONAHA.114.013267
10.1016/j.jacc.2007.11.035
10.1001/archinternmed.2010.271
10.1161/CIRCULATIONAHA.112.114967
10.1016/S0140-6736(09)60738-8
10.1016/j.jacc.2013.02.036
10.1016/j.jcin.2015.08.018
10.1016/S0140-6736(12)62177-1
10.1016/j.thromres.2014.10.016
10.1016/S0733-8651(03)00111-5
Segal JB McNamara RL Miller MR Kim N Goodman SN Powe NR Robinson K Yu D Bass EB . The evidence regarding the drugs used for ventricular rate control. In. J Fam Practice 2000; 49:47–59.
10.1016/S0196-0644(97)70319-6
10.1097/CCM.0b013e3181a02f56
10.1016/S0002-8703(98)70031-6
10.1161/CIRCULATIONAHA.111.019935
10.1016/S0002-9149(97)00962-4
10.1097/00003246-200106000-00011
Hou, 1995, Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone, A randomized, digoxin-controlled study. Eur Heart J, 16, 521, 10.1093/oxfordjournals.eurheartj.a060945
National Institute for Health and Care Excellence (NICE) guidelines. Atrial fibrillation: management. http://www.nice.org.uk/guidance/cg180/ (5 May 2016).
10.1016/j.amjcard.2012.09.020
Goldberger, 2014, Digitalis use in contemporary clinical practice: refitting the foxglove, JAMA Intern Med, 174, 151, 10.1001/jamainternmed.2013.10432
10.1056/NEJM199702203360801
10.1161/CIRCULATIONAHA.106.628347
10.1016/j.tcm.2016.03.011
10.1016/j.jacc.2014.03.060
10.1007/s00228-007-0346-9
10.1136/bmjopen-2012-000888
10.1111/j.1742-1241.2011.02771.x
10.1016/j.jacc.2015.04.045
10.1016/j.jacc.2003.07.020
10.1016/S0735-1097(98)00561-0
10.1016/S0002-9149(99)80538-4
Lewis, 1989, Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation, J Cardiovasc Pharmacol, 13, 1, 10.1097/00005344-198901000-00002
ClinicalTrials.gov. Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF). https://clinicaltrials.gov/ct2/show/NCT02391337 (5 May 2016).
10.1016/j.jacc.2011.06.055
10.1111/j.1540-8159.1997.tb06179.x
10.1016/j.hrthm.2013.01.021
10.1161/CIRCEP.111.967810
10.1161/01.CIR.101.10.1138
10.1056/NEJM200104053441403
10.1007/s11886-012-0330-6
10.1161/CIRCULATIONAHA.106.614560
10.1093/eurheartj/9.7.777
10.1016/j.hrthm.2014.06.007
10.1016/0167-5273(95)02480-K
10.1111/j.1540-8159.2012.03513.x
10.1001/archinte.165.3.258
Lafuente-Lafuente, 2012, Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation, Cochrane Database Syst Rev, 5, CD005049
Roy, 2000, Amiodarone to prevent recurrence of atrial fibrillation, Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med, 342, 913
10.1016/S0140-6736(12)60570-4
10.1111/j.1542-474X.2010.00365.x
10.1136/ebmed-2014-110062
ClinicalTrials.gov. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA). https://clinicaltrials.gov/ct2/show/NCT00911508 (5 May 2016).
10.1016/S0167-5273(02)00467-9
10.1016/S0735-1097(02)02705-5
10.1001/archinte.163.7.777
10.1016/S0167-5273(02)00477-1
10.1016/j.ahj.2003.06.001
Vijayalakshmi, 2006, A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned, Am Heart J, 151, 863, 10.1016/j.ahj.2005.09.009
10.1161/CIRCULATIONAHA.107.723866
10.1161/CIRCEP.109.870204
10.1016/j.jacc.2010.07.046
10.1007/s10557-012-6374-4
Falk, 1997, Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter, Intravenous Dofetilide Investigators. J Am Coll Cardiol, 29, 385, 10.1016/S0735-1097(96)00506-2
10.1007/s00392-013-0586-x
10.1016/j.ijcard.2014.01.099
10.1016/j.amjcard.2013.10.036
10.1016/j.ehj.2004.04.030
Stambler, 1996, Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation, Ibutilide Repeat Dose Study Investigators. Circulation, 94, 1613
10.1016/j.ijcard.2011.10.108
Simon A Niederdoeckl J Skyllouriotis E Schuetz N Herkner H Weiser C Laggner AN Domanovits H Spiel AO . Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department. Europace;doi:10.1093/europace/euw052. Published online ahead of print 22 March 2016.
10.1016/S0002-9149(98)00223-9
Saborido CM Hockenhull J Bagust A Boland A Dickson R Todd D . Systematic review and cost-effectiveness evaluation of ‘pill-in-the-pocket’ strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy. Health Technol Assess 2010;14:iii–iv, 1–75.
10.1016/S0735-1097(00)01116-5
Stroobandt, 1997, Propafenone for conversion and prophylaxis of atrial fibrillation, Propafenone Atrial Fibrillation Trial Investigators. Am J Cardiol, 79, 418
Hughes, 1997, Oral propafenone for rapid conversion of recent onset atrial fibrillation—A review, Can J Cardiol, 13, 839
10.1111/j.1368-5031.2005.00705.x
10.1161/01.CIR.101.11.1282
10.1016/S0140-6736(02)11315-8
10.1136/heartjnl-2015-307656
10.1016/S0167-5273(00)00326-0
10.1016/j.hrthm.2008.10.036
10.1016/j.ehj.2003.10.020
10.1056/NEJM199906173402401
10.1016/0735-1097(96)00230-6
10.1016/j.jacc.2006.05.043
10.1016/S0735-1097(99)00256-9
10.1093/oxfordjournals.eurheartj.a015311
10.1016/j.jacc.2013.04.089
10.2165/00129784-200707030-00006
10.1016/j.thromres.2005.11.016
10.1161/01.CIR.0000120509.64740.DC
10.1056/NEJM200105103441901
10.1056/NEJM199507133330201
10.1016/j.jacc.2009.03.043
10.1016/j.hrthm.2007.07.020
Davy, 2008, Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study, Am Heart J, 156, 527, 10.1016/j.ahj.2008.06.010
Tschuppert, 2007, Effect of dronedarone on renal function in healthy subjects, Br J Clin Pharmacol, 64, 785, 10.1111/j.1365-2125.2007.02998.x
10.1056/NEJM198908103210629
10.1016/j.jacc.2005.01.012
10.1161/CIRCHEARTFAILURE.112.000122
Waldo, 1996, Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators, Survival With Oral d-Sotalol. Lancet, 348, 7
10.1016/S0008-6363(00)00119-X
10.1016/S0195-668X(02)00806-0
10.1111/j.1742-7843.2010.00547.x
10.1016/S0735-1097(99)00226-0
10.1016/j.ehj.2004.06.014
10.1097/FJC.0b013e31824e1b93
10.1097/FJC.0b013e31828780eb
Loose, 2014, Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation, Front Pharmacol, 5, 26, 10.3389/fphar.2014.00026
10.1161/CIRCULATIONAHA.107.724880
10.1161/CIRCEP.115.002856
10.1016/j.amjcard.2012.04.044
10.1016/j.hrthm.2015.01.021
10.1136/heartjnl-2014-305482
Savelieva, 2011, Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines, Part II: secondary prevention. Europace, 13, 610
10.1016/S0735-1097(00)00693-8
Liakopoulos, 2012, Preoperative statin therapy for patients undergoing cardiac surgery, Cochrane Database Syst Rev, 4, Cd008493
10.1016/j.jacc.2012.11.021
10.1016/j.amjcard.2010.07.037
10.1016/j.amjcard.2012.12.020
10.1016/j.jacc.2011.11.063
10.1016/S0196-0644(03)00510-9
10.1016/j.annemergmed.2005.03.002
10.1016/j.annemergmed.2010.09.027
10.1016/S0002-8703(98)70150-4
10.1016/S0002-9149(00)01128-0
10.1161/CIRCULATIONAHA.110.977546
10.1161/01.CIR.0000118472.77237.FA
10.1016/S0140-6736(97)03425-9
10.1056/NEJM200005113421902
10.1161/CIRCEP.108.824789
10.1097/HJH.0b013e3282f35c67
10.1161/CIRCEP.115.003337
10.1161/CIRCEP.114.001672
10.1161/CIRCEP.114.001943
10.1016/j.jacep.2015.02.018
10.1111/j.1540-8167.2008.01275.x
10.1161/CIRCEP.109.859116
10.1016/j.ahj.2012.04.002
10.1016/j.jacep.2016.02.003
10.1161/CIRCULATIONAHA.115.016871
10.1136/heartjnl-2011-300720
10.1161/CIRCEP.115.003019
10.1016/j.jacc.2016.04.015
10.1161/CIRCEP.113.001251
10.1161/CIRCEP.112.971259
10.1016/S0140-6736(15)60026-5
10.1016/j.hrthm.2016.04.016
Lee, 2011, Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center, J Cardiovasc Electrophysiol, 22, 163
10.1161/CIRCEP.114.001759
10.1161/CIRCULATIONAHA.113.004498
10.1111/j.1540-8167.2009.01493.x
10.1161/CIRCEP.113.000768
10.1016/j.jacc.2011.09.028
10.1161/STROKEAHA.111.627067
10.1016/j.hrthm.2014.07.039
10.1111/j.1540-8167.2011.02050.x
10.1111/j.1540-8159.2005.00062.x
10.1161/CIRCEP.113.000760
10.1007/s10840-013-9853-z
10.1016/j.jacc.2011.08.068
10.1161/CIRCEP.113.000899
10.1161/CIRCULATIONAHA.113.006426
10.1016/j.hrthm.2015.02.028
10.1016/j.jacc.2013.11.039
10.1007/s10840-014-9888-9
10.1016/j.amjcard.2014.05.038
10.1016/j.amjcard.2014.10.005
10.1016/j.amjcard.2015.12.027
10.1371/journal.pone.0126512
10.1016/j.jacc.2009.11.039
10.1016/j.hrthm.2013.07.002
10.1016/j.hrthm.2014.08.016
10.1161/CIRCOUTCOMES.111.963108
10.2459/JCM.0000000000000311
Di Biase L Mohanty P Mohanty S Santangeli P Trivedi C Lakkireddy D Reddy M Jais P Themistoclakis S Dello Russo A Casella M Pelargonio G Narducci ML Schweikert R Neuzil P Sanchez J Horton R Beheiry S Hongo R Hao S Rossillo A Forleo G Tondo C Burkhardt JD Haissaguerre M Natale A . Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation; doi:10.1161/CIRCULATIONAHA.115.019406. Published online ahead of print 30 March 2016.
10.1161/CIRCEP.113.000806
10.1016/j.cardfail.2011.07.009
10.1111/j.1540-8167.2005.00245.x
10.1001/jamainternmed.2013.1561
10.1001/jama.1991.03470140088029
Cox, 1991, The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure, J Thorac Cardiovasc Surg, 101, 569, 10.1016/S0022-5223(19)36684-X
10.1016/j.jtcvs.2013.10.084
10.1016/j.jtcvs.2009.12.038
Abreu Filho, 2005, Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease, Circulation, 112, I20, 10.1161/CIRCULATIONAHA.104.526301
10.1016/j.acvd.2009.08.010
10.1016/S1010-7940(03)00377-4
10.1097/IMI.0b013e3181d9199b
10.1016/j.jtcvs.2005.10.020
10.1097/HCO.0b013e32835ced9c
10.1016/j.athoracsur.2007.10.097
10.1510/icvts.2011.271999
10.1177/021849230801600407
10.1016/j.athoracsur.2006.02.030
10.1016/j.ejcts.2008.07.026
10.1016/j.athoracsur.2005.04.060
10.1016/j.jacc.2010.09.055
10.1016/j.athoracsur.2011.12.028
10.1016/j.jtcvs.2014.05.064
10.1016/j.jtcvs.2009.11.065
10.1111/j.1540-8167.2007.00977.x
10.1016/j.jtcvs.2009.11.009
10.1161/CIRCEP.111.961862
Wang, 2014, Comparative study of video-assisted thoracoscopic surgery ablation and radiofrequency catheter ablation on treating paroxysmal atrial fibrillation: a randomized, controlled short-term trial, Chin Med J (Engl), 127, 2567
10.1016/j.jtcvs.2013.10.054
10.1016/j.athoracsur.2008.03.071
10.1371/journal.pone.0022122
10.1016/j.athoracsur.2012.06.010
10.1016/j.athoracsur.2012.01.110
10.1016/j.athoracsur.2012.07.035
10.1016/j.ijcard.2012.04.044
10.1016/j.jacc.2011.12.055
10.1136/heartjnl-2015-307550
10.1016/j.athoracsur.2006.03.075
10.1046/j.1540-8167.2004.03279.x
10.1053/j.semtcvs.2012.04.007
10.1161/CIRCEP.111.963819
10.1016/j.jtcvs.2011.12.018
10.1111/j.1540-8167.1999.tb00293.x
10.1016/S0735-1097(01)01214-1
10.1007/s10840-012-9679-0
10.1016/j.ijcard.2014.06.042
10.1016/S0735-1097(02)02068-5
Wharton JM Sorrentino RA Campbell P Gonzalez-Zuelgaray J Keating E Curtis A Grill C Hafley G Lee K . Effect of pacing modality on atrial tachyarrhythmia recurrence in the tachycardia-bradycardia syndrome: preliminary results of the Pacemaker Atrial Tachycardia Trial. Circulation 1998;98:I–494.
10.1016/j.jacc.2010.05.028
10.1016/j.hrthm.2008.02.007
10.1046/j.1540-8167.2003.03165.x
10.1111/j.1540-8167.2008.01339.x
10.1161/01.CIR.92.10.2929
10.1046/j.1540-8167.2001.00680.x
10.1016/j.hrthm.2009.02.009
10.1161/CIRCULATIONAHA.106.668392
10.1161/CIRCULATIONAHA.107.703330
Watanabe, 2008, Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans, J Clin Invest, 118, 2260
10.1161/01.CIR.0000115205.70330.05
10.1161/01.CIR.0000085071.28695.C4
10.1161/CIRCULATIONAHA.107.711606
10.1016/j.hrthm.2006.12.048
10.1111/j.1540-8167.2007.00766.x
10.1016/j.amjcard.2004.06.024
10.1016/S0735-1097(01)01727-2
10.1161/CIRCRESAHA.107.168294
10.1016/j.jacc.2013.01.073
10.1016/j.amjcard.2010.04.031
10.1016/j.jacc.2003.08.013
Tischenko, 2008, When should we recommend catheter ablation for patients with the Wolff-Parkinson-White syndrome?, Curr Opin Cardiol, 23, 32, 10.1097/HCO.0b013e3282f26d1b
10.1016/j.ancard.2007.05.006
10.1016/0735-1097(90)90384-2
10.1111/j.1540-8159.1991.tb02810.x
10.1001/archinte.1987.00370100020005
10.1007/s11739-010-0385-6
10.1136/heartjnl-2013-304276
10.1111/j.1540-8167.2008.01192.x
10.1016/j.amjcard.2006.12.087
10.1016/j.hrthm.2005.11.013
10.1016/j.jacc.2012.04.030
10.1016/j.jacc.2011.11.039
10.1016/j.hrthm.2013.10.043
10.1161/CIRCULATIONAHA.107.757955
10.1046/j.1540-8167.2002.00231.x
10.1016/S0002-9149(99)80136-2
10.1016/0735-1097(95)00519-6
10.1016/j.hrthm.2015.09.017
10.1016/j.jacc.2014.05.003
10.1016/S0735-1097(10)80014-2
10.1161/CIRCULATIONAHA.108.785626
10.1016/j.ijcard.2005.05.020
10.1136/heartjnl-2013-303825
10.1016/j.amjcard.2011.03.086
10.1016/j.jacc.2013.01.091
Karjalainen, 1998, Lone atrial fibrillation in vigorously exercising middle aged men: case-control study, BMJ, 316, 1784, 10.1136/bmj.316.7147.1784
10.1016/j.amjcard.2010.10.049
10.1097/01.hjr.0000216543.54066.72
10.1016/j.amjcard.2005.11.041
10.1016/j.jacep.2015.04.013
10.1016/0002-8703(95)90090-X
Magee, 2003, Oral beta-blockers for mild to moderate hypertension during pregnancy, Cochrane Database Syst Rev, 3, CD002863
10.2165/00003088-198712040-00002
10.1016/S0167-5273(02)00601-0
Joint Formulary Committee. British National Formulary (online). http://www.medicinescomplete.com (2 December 2014).
10.1161/CIRCULATIONAHA.111.026120
10.1007/s12471-011-0077-5
10.1016/S1701-2163(16)34767-3
10.1016/j.athoracsur.2006.11.047
Arsenault, 2013, Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery, Cochrane Database Syst Rev, 1, Cd003611
10.1111/j.1445-5994.2012.02844.x
10.1097/HCO.0b013e32835b0956
10.1097/FJC.0000000000000102
10.1016/j.athoracsur.2012.09.008
10.1053/j.jvca.2012.03.012
10.1016/j.jtcvs.2013.03.015
10.1016/j.amjcard.2011.04.036
10.1016/j.jacc.2013.07.014
10.1161/CIRCEP.109.899633
10.1371/journal.pone.0072913
10.1016/j.jjcc.2013.06.014
10.1053/j.jvca.2010.03.015
10.1016/j.ejcts.2006.09.003
10.1016/j.athoracsur.2014.03.039
10.1016/j.amjcard.2011.08.033
10.1080/14017430802702291
10.1016/j.ejcts.2009.12.033
10.1161/CIRCULATIONAHA.108.777789
10.1016/j.jacc.2003.11.023
10.1016/j.jacc.2009.10.058
10.1016/j.cll.2014.06.012
10.3109/14017431.2012.740572
10.1016/j.ijcard.2010.09.028
10.1016/j.ccell.2011.04.001
10.1161/CIRCULATIONAHA.112.104786
Jensen, 2014, Anticoagulation in adults with congenital heart disease: The who, the when and the how?, Heart, 101, 424, 10.1136/heartjnl-2014-305576
10.1016/j.jjcc.2009.01.009
10.1016/0735-1097(94)90121-X
10.1016/j.ijcard.2007.06.019
10.1016/S0195-668X(02)00383-4
10.1016/j.ijcard.2010.07.014
de Salle, 1975, [Rhythm disorders occurring after surgical closure of the interatrial communication], Acta Cardiol, 30, 239
10.1111/j.1540-8159.1997.tb06207.x
Porter, 1993, Incidence and management of dysrhythmias after Fontan procedure, Herz, 18, 318
10.1016/0735-1097(94)90181-3
10.1111/j.1540-8191.2009.00914.x
10.1053/j.pcsu.2008.03.001
10.1111/j.1540-8159.2008.00947.x
10.1007/s10840-007-9181-2
10.1161/CIRCEP.114.001758
10.1161/CIRCULATIONAHA.109.928481
Kobayashi, 1998, Maze procedure for atrial fibrillation associated with atrial septal defect, Circulation, 98, II399
10.5090/kjtcs.2013.46.2.98
Gutierrez, 2013, Atrial tachyarrhythmias and the Cox-maze procedure in congenital heart disease, Congenit Heart Dis, 8, 434
10.1161/CIRCEP.113.000313
10.1161/01.CIR.0000027683.00417.9A
10.1007/s00392-014-0682-6
Bronis, 2012, Vernakalant: review of a novel atrial selective antiarrhythmic agent and its place in current treatment of atrial fibrillation, Hosp Chronicles, 7, 171
10.3122/jabfm.2011.01.080096
10.1016/j.ajem.2008.10.028
10.1016/S0002-8703(99)70489-8
Manolis, 2013, Transesophageal overdrive pacing: A simple and versatile tool, Hosp Chronicles, 8, 143
Poulidakis, 2014, Transvenous temporary cardiac pacing, Rhythmos, 9, 20
10.1016/j.amjcard.2009.04.040
10.1016/S0195-668X(02)00846-1
10.2459/JCM.0b013e3283403301
10.1371/journal.pone.0100509
10.1016/j.hrthm.2008.12.013
Institute of Medicine Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington (DC): National Academies Press (US); 2001.
10.1377/hlthaff.2012.1061
10.1111/j.1751-7117.2008.07351.x
Clarkesmith, 2013, Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation, Cochrane Database Syst Rev, 6, Cd008600
10.1371/journal.pone.0074037
10.1016/j.ijcard.2012.12.047
McCabe, 2011, What patients want and need to know about atrial fibrillation, J Multidiscip Healthc, 4, 413, 10.2147/JMDH.S19315
10.1207/S15324796ABM2601_01
Stacey, 2014, Decision aids for people facing health treatment or screening decisions, Cochrane Database Syst Rev, 1, CD001431
10.1007/s11606-012-2077-6
10.1016/j.hrthm.2014.11.011
10.1186/s13063-015-0898-4
10.1023/B:CEPR.0000023139.45437.93
10.1016/j.avsg.2011.09.009
10.1016/S0140-6736(99)05388-X
10.1016/j.jvs.2014.11.001
10.1016/j.jtcvs.2005.03.041
10.1016/j.jtcvs.2008.01.035
10.1016/j.jtcvs.2009.06.033
Papworth Hospital NHS Foundation Trust. A randomised controlled trial to investigate the clinical and cost effectiveness of adding an ablation device-based maze procedure as a routine adjunct to elective cardiac surgery for patients with pre-existing atrial fibrillation. http://www.isrctn.com/ISRCTN82731440 (5 May 2016).
Amit G, Nyong J, Morillo CA, Casas JP, Adler AJ, Owolabi OO, Perel P, Prieto-Merino D, Lambiase P. Efficacy and safety of ablation for patients with non-paroxysmal atrial fibrillation. Cochrane Database of Systematic Reviews 2016; 8: CD012088. DOI: 10.1002/14651858.CD012088.pub2.
Huffman MD, Karmali KN, Berendsen MA, Andrei A-C, Kruse J, McCarthy PM, Malaisrie CS. Concomitant atrial fibrillation surgery for people undergoing cardiac surgery. Cochrane Database of Systematic Reviews 2016; 8: CD011814. DOI: 10.1002/14651858.CD011814.pub2.
Allen V, Banerjee A, SHah AD, Patel, R, Denaxas S, Casas J-P, Hemingway H. Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and acros primary and secondary care. Heart, http://dx.doi.org/10.1136/heartjnl-2016-309910 .
Kirchhof P Calkins H . Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J 2016;doi:10.1093/eurheartj/ehw260.
